FIRE1's innovative Norm heart failure management solution aims to empower patients through self-monitoring, improving their ability to manage chronic heart conditions from home.
The company's recent funding allows it to conduct a pivotal clinical trial to validate their system, which targets fluid overload—a key feature in managing heart failure.
With FDA Breakthrough Device Designation, FIRE1 is positioned to lead the transformation in heart failure management, akin to advancements in diabetes care through continuous monitoring.
The goal of the FUTURE-HF study is to demonstrate that the FIRE1 System can significantly improve health outcomes for heart failure patients, enhancing their quality of life.
Collection
[
|
...
]